Dose ranging and dosing regime is studied in Phase II trials. It is tempting to speculate now, but as you stated, you cannot simply compare various animals to humans.
It all looks pretty good though I think, the risks are getting less, some more patience needed though
Ann: Positive safety data from 4th Cohort -Phase I Clinical Trial, page-19
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.5¢ |
Change
0.015(3.19%) |
Mkt cap ! $112.4M | |||
| Open | High | Low | Value | Volume |
| 47.5¢ | 49.0¢ | 47.5¢ | $83.1K | 172.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 110909 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.5¢ | 17499 | 1 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| RCE (ASX) Chart |